Abstract

Clinical decision-making and outcome research in Oncology requires timely access to fit-for-purpose, real-world data (RWD). RWD assessment frameworks for secondary use of healthcare data therefore need to include dimensions that evaluate data quality using fit-for-purpose evaluation criteria. This conceptual paper describes the Use-case specific Relevance and Quality Assessment (‘UReQA’, pronounced as ‘Eureka’) framework and its implementation for outcomes studies that estimate real-world Time to Treatment Discontinuation (TTD).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call